Self-Enhancement of Hepatitis C Virus Replication by Promotion of Specific Sphingolipid Biosynthesis

Lipids are key components in the viral life cycle that affect host-pathogen interactions. In this study, we investigated the effect of HCV infection on sphingolipid metabolism, especially on endogenous SM levels, and the relationship between HCV replication and endogenous SM molecular species. We demonstrated that HCV induces the expression of the genes (SGMS1 and 2) encoding human SM synthases 1 and 2. We observed associated increases of both total and individual sphingolipid molecular species, as assessed in human hepatocytes and in the detergent-resistant membrane (DRM) fraction in which HCV replicates. SGMS1 expression had a correlation with HCV replication. Inhibition of sphingolipid biosynthesis with a hepatotropic serine palmitoyltransferase (SPT) inhibitor, NA808, suppressed HCV-RNA production while also interfering with sphingolipid metabolism. Further, we identified the SM molecular species that comprise the DRM fraction and demonstrated that these endogenous SM species interacted with HCV nonstructural 5B polymerase to enhance viral replication. Our results reveal that HCV alters sphingolipid metabolism to promote viral replication, providing new insights into the formation of the HCV replication complex and the involvement of host lipids in the HCV life cycle.

[1]  Y. Hirata,et al.  Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. , 2011, Journal of hepatology.

[2]  K. Ikeda,et al.  Increase of oxidant‐related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice , 2011, Cancer science.

[3]  Y. Hirata,et al.  Sphingomyelin Activates Hepatitis C Virus RNA Polymerase in a Genotype-Specific Manner , 2010, Journal of Virology.

[4]  A. Siddiqui,et al.  Hepatitis C virus hijacks host lipid metabolism , 2010, Trends in Endocrinology & Metabolism.

[5]  Qibin Zhang,et al.  Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics , 2010, PLoS pathogens.

[6]  Ryo Taguchi,et al.  Global analysis of triacylglycerols including oxidized molecular species by reverse-phase high resolution LC/ESI-QTOF MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  J. Helms,et al.  Lipids in host–pathogen interactions: Pathogens exploit the complexity of the host cell lipidome , 2009, Progress in Lipid Research.

[8]  John A. Tallarico,et al.  Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication , 2009, Journal of Virology.

[9]  N. Heaton,et al.  Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication , 2009, Proceedings of the National Academy of Sciences.

[10]  G. Kukolj,et al.  Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. , 2009, Virology.

[11]  Raymond T Chung,et al.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. , 2009, Cell host & microbe.

[12]  Y. Inoue,et al.  Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection , 2008, Journal of Virology.

[13]  N. Enomoto,et al.  Targeting lipid metabolism in the treatment of hepatitis C virus infection. , 2008, The Journal of infectious diseases.

[14]  Marina A Gritsenko,et al.  Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction , 2007, Hepatology.

[15]  M. Kohara,et al.  Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo , 2007, Hepatology.

[16]  N. Loberto,et al.  Ceramide and sphingomyelin species of fibroblasts and neurons in culture Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.

[17]  N. Sharma,et al.  Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  M. Wenk.  Lipidomics of host–pathogen interactions , 2006, FEBS letters.

[19]  K. Chayama,et al.  Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. , 2006, Biochemical and biophysical research communications.

[20]  M. Kohara,et al.  Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype , 2006, Gene Therapy.

[21]  Hans-Georg Kräusslich,et al.  The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Aoki,et al.  Host sphingolipid biosynthesis as a target for hepatitis C virus therapy , 2005, Nature chemical biology.

[23]  F. Chisari,et al.  Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Rekhter,et al.  Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice , 2004, Circulation.

[25]  Y. Kozutsumi,et al.  Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase. , 2004, Blood.

[26]  T. Asahara,et al.  Near completely humanized liver in mice shows human-type metabolic responses to drugs. , 2004, The American journal of pathology.

[27]  Toshihide Kobayashi,et al.  [Imaging lipid rafts]. , 2004, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[28]  M. Lai,et al.  Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. , 2004, Virology.

[29]  J. Brouwers,et al.  Identification of a family of animal sphingomyelin synthases , 2004, The EMBO journal.

[30]  K. Shimotohno,et al.  Hepatitis C Virus Non-structural Proteins in the Probable Membranous Compartment Function in Viral Genome Replication* , 2003, Journal of Biological Chemistry.

[31]  Soon B. Hwang,et al.  Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2 , 2003, Journal of Virology.

[32]  Y. Hannun,et al.  Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.

[33]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Slotte,et al.  Membrane properties of sphingomyelins , 2002, FEBS letters.

[35]  A. Siddiqui,et al.  Hepatitis C Virus Subgenomic Replicons Induce Endoplasmic Reticulum Stress Activating an Intracellular Signaling Pathway , 2002, Journal of Virology.

[36]  D. Tyrrell,et al.  Hepatitis C virus replication in mice with chimeric human livers , 2001, Nature Medicine.

[37]  Y. Hannun,et al.  Enzymes of sphingolipid metabolism: from modular to integrative signaling. , 2001, Biochemistry.

[38]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[39]  W. V. van Blitterswijk,et al.  Sphingomyelin Hydrolysis to Ceramide during the Execution Phase of Apoptosis Results from Phospholipid Scrambling and Alters Cell-Surface Morphology , 2000, The Journal of cell biology.

[40]  J. Pfeilschifter,et al.  Physiology and pathophysiology of sphingolipid metabolism and signaling. , 2000, Biochimica et biophysica acta.

[41]  A. Giuliano,et al.  Uncoupling Ceramide Glycosylation by Transfection of Glucosylceramide Synthase Antisense Reverses Adriamycin Resistance* , 2000, The Journal of Biological Chemistry.

[42]  M. Kohara,et al.  Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). , 1996, Journal of immunological methods.

[43]  Y. Miyake,et al.  Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. , 1995, Biochemical and biophysical research communications.

[44]  G. van Meer,et al.  The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei. , 1994, Virology.

[45]  T. Okumoto,et al.  Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. , 1994, The Journal of antibiotics.

[46]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[47]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[48]  R. Taguchi,et al.  methods Targeted analysis of ganglioside and sulfatide molecular species by LC/ESI-MS/MS with theoretically expanded multiple reaction monitoring , 2008 .

[49]  Takao Shimizu,et al.  Basic analytical systems for lipidomics by mass spectrometry in Japan. , 2007, Methods in enzymology.

[50]  S. Spiegel,et al.  Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology. , 1997, Toxicology and applied pharmacology.